Literature DB >> 2789221

Calcium binding to the isolated beta-hydroxyaspartic acid-containing epidermal growth factor-like domain of bovine factor X.

E Persson1, M Selander, S Linse, T Drakenberg, A K Ohlin, J Stenflo.   

Abstract

Coagulation factor X is a vitamin K-dependent protein composed of discrete domains or modules. A proteolytically modified derivative of factor X that lacks the NH2-terminal gamma-carboxyglutamic acid (Gla)-containing region retains one Ca2+ binding site. To localize this Gla-independent Ca2+ binding site and to facilitate future studies aimed at elucidating structure-function relationship in the factor X molecule, we have devised a method to isolate the first beta-hydroxyaspartic acid (Hya)-containing epidermal growth factor (EGF)-like domain from proteolytic digests of bovine factor X performed under strictly controlled conditions. The EGF-like domain, corresponding to residues 45-86 in bovine factor X, was obtained in more than 50% recovery, and was at least 98% homogeneous as judged by NH2-terminal sequence analysis. Ca2+ binding to the isolated EGF-like domain was studied by 1H NMR spectroscopy. On binding of Ca2+ to the domain the resonances from Tyr-68 centered at 6.8 ppm were affected. The Ca2+ concentration dependence of the chemical shift was used to calculate the Ca2+ binding constant, resulting in a K alpha of 4 X 10(3) M-1 at pH 8.5 and 1 X 10(3) M-1 at pH 7.4, the higher value presumably reflecting an increase in negative surface charge due to deprotonation of a histidine residue with a pK alpha of 7.4. The NMR spectra gave no evidence of a conformational change in the EGF-like domain between pH 6 and 8.5.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2789221

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  The three-dimensional structure of the first EGF-like module of human factor IX: comparison with EGF and TGF-alpha.

Authors:  M Baron; D G Norman; T S Harvey; P A Handford; M Mayhew; A G Tse; G G Brownlee; I D Campbell
Journal:  Protein Sci       Date:  1992-01       Impact factor: 6.725

2.  Structural basis for the negative allostery between Ca(2+)- and Mg(2+)-binding in the intracellular Ca(2+)-receptor calbindin D9k.

Authors:  M Andersson; A Malmendal; S Linse; I Ivarsson; S Forsén; L A Svensson
Journal:  Protein Sci       Date:  1997-06       Impact factor: 6.725

3.  An anticoagulant RNA aptamer that inhibits proteinase-cofactor interactions within prothrombinase.

Authors:  Sai K Buddai; Juliana M Layzer; Genmin Lu; Christopher P Rusconi; Bruce A Sullenger; Dougald M Monroe; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

4.  Structure and dynamics of zymogen human blood coagulation factor X.

Authors:  Divi Venkateswarlu; Lalith Perera; Tom Darden; Lee G Pedersen
Journal:  Biophys J       Date:  2002-03       Impact factor: 4.033

5.  Calcium binding to tandem repeats of EGF-like modules. Expression and characterization of the EGF-like modules of human Notch-1 implicated in receptor-ligand interactions.

Authors:  M D Rand; A Lindblom; J Carlson; B O Villoutreix; J Stenflo
Journal:  Protein Sci       Date:  1997-10       Impact factor: 6.725

6.  Ca2(+)-sensitive binding of thrombospondin to U937 cells is due to the formation of calcium precipitate in the binding medium.

Authors:  X Sun; D F Mosher
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

7.  The first EGF-like domain from human factor IX contains a high-affinity calcium binding site.

Authors:  P A Handford; M Baron; M Mayhew; A Willis; T Beesley; G G Brownlee; I D Campbell
Journal:  EMBO J       Date:  1990-02       Impact factor: 11.598

8.  Recombinant human protein C derivatives: altered response to calcium resulting in enhanced activation by thrombin.

Authors:  H J Ehrlich; B W Grinnell; S R Jaskunas; C T Esmon; S B Yan; N U Bang
Journal:  EMBO J       Date:  1990-08       Impact factor: 11.598

9.  Structure and expression of fibulin-2, a novel extracellular matrix protein with multiple EGF-like repeats and consensus motifs for calcium binding.

Authors:  T C Pan; T Sasaki; R Z Zhang; R Fässler; R Timpl; M L Chu
Journal:  J Cell Biol       Date:  1993-12       Impact factor: 10.539

Review 10.  Aspartate β-hydroxylase as a target for cancer therapy.

Authors:  Madiha Kanwal; Michal Smahel; Mark Olsen; Jana Smahelova; Ruth Tachezy
Journal:  J Exp Clin Cancer Res       Date:  2020-08-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.